A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences